{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:09:10Z","timestamp":1792786150034,"version":"4.5.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Guangxi Zhuang Autonomous Region Health and Family Planning Commission Projects","award":["Z-B20232008"],"award-info":[{"award-number":["Z-B20232008"]}],"id":[{"id":"https:\/\/ror.org\/022z3g211","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      This retrospective observational study primarily aims to analyze the clinical characteristics and prognosis of patients with antibody-mediated autoimmune encephalitis (AE) in Liuzhou, China. We retrospectively reviewed the medical records of 32 patients diagnosed with acute AE between January 1, 2017, and August 31, 2024, for the following parameters: clinical features, results of laboratory and imaging studies, treatment, and clinical outcomes. Anti-N-methyl-d-aspartate receptor encephalitis was the most prevalent subtype (50%, 16\/32). Other subtypes included glial fibrillary acidic protein astrocytopathy encephalitis (12.5%, 4\/32), anti-myelin oligodendrocyte glycoprotein encephalitis (12.5%, 4\/32), anti-leucine glioma inactivating protein 1 encephalitis (6.3%, 2\/32), anti-GAD65 encephalitis (6.3%, 2\/32), anti-GABABR encephalitis (6.3%, 2\/32), and anti-contactin-associated protein-like 2 encephalitis (6.3%, 2\/32). The most common prodromal manifestation were fever or influenza-like illness (56.25%). The primary clinical manifestations included seizures (25.68%), psychiatric and behavioral disorders (17.57%), disturbances in consciousness (9.46%), and dyssomnia (9.46%). Pneumonia, observed in 43.75% (14\/32) of patients, was associated with older age (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.017), higher intensive care unit admission rates (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.042), increased need for mechanical ventilation (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.002), and worse modified Rankin Scale scores at diagnosis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.005). Immunotherapy led to clinical improvement in most cases (78.13%), and these patients achieved favorable outcomes (modified Rankin Scale\u2005\u2264\u20052; median follow-up 37 months). In conclusion, the AE characteristics in our single-center retrospective study were consistent with previous findings. The proportion of anti-\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      -methyl-\n                      <jats:sc>d<\/jats:sc>\n                      -aspartate receptor encephalitis was the highest. Once AE is diagnosed, immunotherapy should be initiated promptly to reduce disease severity and improve outcomes. In clinical practice for AE management, emphasis should be placed on pneumonia prevention and treatment to reduce the rate of intensive care unit admission and mechanical ventilation and shorten the length of hospitalization.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049565","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:01:14Z","timestamp":1783720874000},"page":"e49565","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and prognosis of antibody-mediated autoimmune encephalitis: A single-center cohort study in Liuzhou, China"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7855-1128","authenticated-orcid":false,"given":"Yanyan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Neurology, Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoquan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261001","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis.","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med"},{"key":"R2-20261001","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis.","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol"},{"key":"R3-20261001","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/WCO.0000000000000087","article-title":"Autoimmune encephalitis as differential diagnosis of infectious encephalitis.","volume":"27","author":"Armangue","year":"2014","journal-title":"Curr Opin Neurol"},{"key":"R4-20261001","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"R5-20261001","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","article-title":"Antibodies and neuronal autoimmune disorders of the CNS.","volume":"257","author":"Graus","year":"2010","journal-title":"J Neurol"},{"key":"R6-20261001","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1177\/1352458519837705","article-title":"MOG antibody-associated encephalomyelitis\/encephalitis.","volume":"25","author":"Salama","year":"2019","journal-title":"Mult Scler"},{"key":"R7-20261001","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis.","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol"},{"key":"R8-20261001","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp-2020-325302","article-title":"Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management.","volume":"92","author":"Abboud","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R9-20261001","doi-asserted-by":"crossref","first-page":"1258048","DOI":"10.3389\/fimmu.2023.1258048","article-title":"Autoimmune GFAP astrocytopathy after viral encephalitis: a case report of bimodal overlapping encephalitis.","volume":"14","author":"Cheng","year":"2023","journal-title":"Front Immunol"},{"key":"R10-20261001","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3389\/fneur.2018.00706","article-title":"Systematic review: syndromes, early diagnosis, and treatment in autoimmune encephalitis.","volume":"9","author":"Hermetter","year":"2018","journal-title":"Front Neurol"},{"key":"R11-20261001","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis.","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"R12-20261001","doi-asserted-by":"crossref","first-page":"611597","DOI":"10.3389\/fneur.2021.611597","article-title":"Clinical characteristics and outcome of neuronal surface antibody-mediated autoimmune encephalitis patients in a national cohort.","volume":"12","author":"Hayden","year":"2021","journal-title":"Front Neurol"},{"key":"R13-20261001","doi-asserted-by":"crossref","first-page":"1213532","DOI":"10.3389\/fimmu.2023.1213532","article-title":"Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China.","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol"},{"key":"R14-20261001","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fneur.2019.00539","article-title":"Clinical characteristics and short-term prognosis of autoimmune encephalitis: a single-center cohort study in Changsha, China.","volume":"10","author":"Deng","year":"2019","journal-title":"Front Neurol"},{"key":"R15-20261001","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"R16-20261001","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models.","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol"},{"key":"R17-20261001","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00415-025-13159-0","article-title":"Clinical course and long-term outcomes in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy.","volume":"272","author":"Arzalluz-Luque","year":"2025","journal-title":"J Neurol"},{"key":"R18-20261001","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/a-2607-6261","article-title":"Impact of anti-MOG antibody in diagnosis of autoimmune diseases of the central nervous system in children: a case series.","volume":"56","author":"L\u00f3pez-Mora","year":"2025","journal-title":"Neuropediatrics"},{"key":"R19-20261001","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4103\/aian.aian_392_23","article-title":"Neurological manifestations of glutamic acid decarboxylase autoimmunity in Indian patients.","volume":"26","author":"Thevarkalam","year":"2023","journal-title":"Ann Indian Acad Neurol"},{"key":"R20-20261001","doi-asserted-by":"crossref","first-page":"652864","DOI":"10.3389\/fimmu.2021.652864","article-title":"Clinical character of CASPR2 autoimmune encephalitis: a multiple center retrospective study.","volume":"12","author":"Qin","year":"2021","journal-title":"Front Immunol"},{"key":"R21-20261001","doi-asserted-by":"crossref","first-page":"577673","DOI":"10.1016\/j.jneuroim.2021.577673","article-title":"Seasonal variation in autoimmune encephalitis: a multi-center retrospective study.","volume":"359","author":"Lai","year":"2021","journal-title":"J Neuroimmunol"},{"key":"R22-20261001","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"R23-20261001","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2147\/JPR.S189301","article-title":"Emerging role of prodromal headache in patients with anti-N-methyl-D-aspartate receptor encephalitis.","volume":"12","author":"Ma","year":"2019","journal-title":"J Pain Res"},{"key":"R24-20261001","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/QCO.0000000000000554","article-title":"Herpes simplex virus encephalitis update.","volume":"32","author":"Stahl","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"R25-20261001","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/jnnp-2022-330626","article-title":"Early autoimmunity and outcome in virus encephalitis: a retrospective study based on tissue-based assay.","volume":"94","author":"Liu","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R26-20261001","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1111\/cns.14336","article-title":"Epstein\u2013Barr virus: to be a trigger of autoimmune glial fibrillary acidic protein astrocytopathy?","volume":"29","author":"Li","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"R27-20261001","doi-asserted-by":"crossref","first-page":"e16284","DOI":"10.1111\/ene.16284","article-title":"Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: a systematic review and meta\u2010analysis.","volume":"31","author":"Hagbohm","year":"2024","journal-title":"Eur J Neurol"},{"key":"R28-20261001","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis.","volume":"13","author":"van Sonderen","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"R29-20261001","doi-asserted-by":"crossref","first-page":"e42472","DOI":"10.1097\/MD.0000000000042472","article-title":"Approach and overview of autoimmune encephalitis: a review.","volume":"104","author":"Yucel","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"R30-20261001","doi-asserted-by":"crossref","first-page":"577285","DOI":"10.1016\/j.jneuroim.2020.577285","article-title":"Searching for autoimmune encephalitis: beware of normal CSF.","volume":"345","author":"H\u00e9bert","year":"2020","journal-title":"J Neuroimmunol"},{"key":"R31-20261001","doi-asserted-by":"crossref","first-page":"e1086","DOI":"10.1212\/NXI.0000000000001086","article-title":"CSF findings in acute NMDAR and LGI1 antibody-associated autoimmune encephalitis.","volume":"8","author":"D\u00fcrr","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R32-20261001","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/epi.16807","article-title":"Seizures in autoimmune encephalitis-a systematic review and quantitative synthesis.","volume":"62","author":"Yeshokumar","year":"2021","journal-title":"Epilepsia"},{"key":"R33-20261001","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.21037\/apm-19-484","article-title":"Clinical and EEG characteristics analysis of autoimmune encephalitis in children with positive and negative anti-N-methyl- D-aspartate receptor antibodies.","volume":"9","author":"Tong","year":"2020","journal-title":"Ann Palliat Med"},{"key":"R34-20261001","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/WNP.0000000000000654","article-title":"Continuous EEG findings in autoimmune encephalitis.","volume":"38","author":"Moise","year":"2021","journal-title":"J Clin Neurophysiol"},{"key":"R35-20261001","doi-asserted-by":"crossref","first-page":"1510722","DOI":"10.3389\/fneur.2025.1510722","article-title":"Electroencephalographic biomarkers of antibody-mediated autoimmune encephalitis.","volume":"16","author":"Sun","year":"2025","journal-title":"Front Neurol"},{"key":"R36-20261001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.10.014","article-title":"Prognosticating autoimmune encephalitis: a systematic review.","volume":"96","author":"Broadley","year":"2019","journal-title":"J Autoimmun"},{"key":"R37-20261001","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3389\/fimmu.2019.01286","article-title":"Analysis of clinical characteristics and poor prognostic predictors in patients with an initial diagnosis of autoimmune encephalitis.","volume":"10","author":"Qiu","year":"2019","journal-title":"Front Immunol"},{"key":"R38-20261001","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"R39-20261001","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ana.25216","article-title":"Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis.","volume":"83","author":"Mueller","year":"2018","journal-title":"Ann Neurol"},{"key":"R40-20261001","doi-asserted-by":"crossref","first-page":"1756285617722347","DOI":"10.1177\/1756285617722347","article-title":"Treatment strategies for autoimmune encephalitis.","volume":"11","author":"Shin","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"R41-20261001","doi-asserted-by":"crossref","first-page":"918396","DOI":"10.3389\/fimmu.2022.918396","article-title":"Relapses of anti-NMDAR, anti-GABABR and anti-LGI1 encephalitis: a retrospective cohort study.","volume":"13","author":"Zhong","year":"2022","journal-title":"Front Immunol"},{"key":"R42-20261001","doi-asserted-by":"crossref","first-page":"e19802","DOI":"10.1097\/MD.0000000000019802","article-title":"Risk factors for pneumonia in patients with anti-NMDA receptor encephalitis.","volume":"99","author":"Miao","year":"2020","journal-title":"Medicine (Baltimore)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:00:28Z","timestamp":1790881228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":42,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049565","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"2025-10-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}